Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2024

    read more

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Colon to Rectum

    Mirikizumab as induction and maintenance therapy for ulcerative colitis

    N Engl J Med. 2023;388(26):2444–55

    D’Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group

    Go to article

    Colon to Rectum

    Efficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort study

    Aliment Pharmacol Ther. 2023;58(3):297–308

    Kochhar GS, Desai A, Farraye FA, Cross RK, El-Hachem S, Dulai PS, Regueiro M

    Go to article

    Colon to Rectum

    Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries – A nationwide cohort study

    Aliment Pharmacol Ther. 2023;58(1):48–59

    Mertz Nørgård B, Dijkstra Zegers F, Knudsen T, Kjeldsen J, Lund K, Brodersen JB, Nielsen J

    Go to article

    Colon to Rectum

    Food processing and risk of inflammatory bowel disease: A systematic review and meta-analysis

    Clin Gastroenterol Hepatol. 2023;21(10):2483–95.e1

    Narula N, Chang NH, Mohammad D, Wong ECL, Ananthakrishnan AN, Chan SSM, Carbonnel F, Meyer A

    Go to article

    Colon to Rectum

    Associations of antibiotics, hormonal therapies, oral contraceptives, and long-term NSAIDs with inflammatory bowel disease: Results from the Prospective Urban Rural Epidemiology (PURE) study

    Clin Gastroenterol Hepatol. 2023;21(10):2649–59.e16

    Narula N, Wong ECL, Pray C, Marshall JK, Rangarajan S, Islam S, Bahonar A, Alhabib KF, Kontsevaya A, Ariffin F, Co HU, Al Sharief W, Szuba A, Wielgosz A, Diaz ML, Yusuf R, Kruger L, Soman B, Li Y, Wang C, Yin L, Mirrakhimov E, Lanas F, Davletov K, Rosengren A, Lopez-Jaramillo P, Khatib R, Oguz A, Iqbal R, Yeates K, Avezum Á, Reinisch W, Moayyedi P, Yusuf S

    Go to article

    Colon to Rectum

    Comparative safety of biologic agents in patients with inflammatory bowel disease with active or recent malignancy: A multicenter cohort study

    Clin Gastroenterol Hepatol. 2023;21(6):1598–606.e5

    Holmer AK, Luo J, Russ KB, Park S, Yang JY, Ertem F, Dueker J, Nguyen V, Hong S, Zenger C, Axelrad JE, Sofia A, Petrov JC, Al-Bawardy B, Fudman DI, Llano E, Dailey J, Jangi S, Khakoo N, Damas OM, Barnes EL, Scott FI, Ungaro RC, Singh S; Rising Educators Academics and Clinicians Helping-IBD (REACH-IBD)

    Go to article

    Colon to Rectum

    Food processing and risk of Crohn’s disease and ulcerative colitis: A European prospective cohort study

    Clin Gastroenterol Hepatol. 2023;21(6):1607–16.e6

    Meyer A, Dong C, Casagrande C, Chan SSM, Huybrechts I, Nicolas G, Rauber F, Bertazzi Levy R, Millett C, Oldenburg B, Weiderpass E, Heath AK, Tong TYN, Tjønneland A, Kyrø C, Kaaks R, Katzke VA, Bergman MM, Palli D, Masala G, Tumino R, Sacerdote C, Colorado-Yohar SM, Sánchez MJ, Grip O, Lindgren S, Luben R, Gunter MJ, Mahamat-Saleh Y, Boutron-Ruault MC, Carbonnel F

    Go to article

    Colon to Rectum

    Mercaptopurine for the treatment of ulcerative colitis: A randomized placebo-controlled trial

    J Crohns Colitis. 2023;17(7):1055–65

    Löwenberg M, Volkers A, van Gennep S, Mookhoek A, Montazeri N, Clasquin E, Duijvestein M, van Bodegraven A, Rietdijk S, Jansen J, van Asseldonk D, van der Zanden E, Dijkgraaf M, West R, de Boer N, D’Haens G

    Go to article

    Colon to Rectum

    Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naive patients with ulcerative colitis: A 2-year propensity-score-adjusted analysis from the prospective, observational VEDOIBD study

    Aliment Pharmacol Ther. 2023;58(4):429–42

    Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Efken P, Mohl W, Krause T, Hoffstadt M, Ehehalt R, Trentmann L, Schweitzer A, Jessen P, Hartmann P, Schreiber S

    Go to article